{"id":1248,"date":"2026-11-02T08:59:11","date_gmt":"2026-11-02T06:59:11","guid":{"rendered":"https:\/\/www.pqra.gr\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\/"},"modified":"2026-11-02T09:03:09","modified_gmt":"2026-11-02T07:03:09","slug":"preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders","status":"publish","type":"post","link":"https:\/\/www.pqra.gr\/el\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\/","title":{"rendered":"Preparing for the EU Pharma Reform: A Practical Readiness Checklist for Marketing Authorisation Holders"},"content":{"rendered":"<p style=\"font-size:19px;line-height:1.7;color:#33414d;\"><strong>With the reform of EU pharmaceutical legislation moving towards publication, companies have a window to prepare. A phased approach avoids both premature spending and last-minute scrambling.<\/strong><\/p>\n<h2>Step one: map your portfolio<\/h2>\n<p>Classify products by status: authorised, under assessment, planned for submission before late 2028, or planned after. Published analyses indicate that procedures submitted before the relevant application dates are expected to be completed under current rules, so submission timing now has strategic value.<\/p>\n<h2>Step two: identify early obligations<\/h2>\n<ul><li><strong>Shortage duties.<\/strong> Notification and prevention plans are reported to apply around six months after entry into force.<\/li><li><strong>Supply requests.<\/strong> Member State requests to place products on the market are reported to follow around one year after entry into force.<\/li><li><strong>Early provisions.<\/strong> Vouchers, sandboxes and critical medicine measures apply from entry into force.<\/li><\/ul>\n<h2>Step three: review internal capability<\/h2>\n<p>Regulatory affairs, pharmacovigilance, quality and supply teams will each need updated procedures. Governance for shortage notification, launch commitments and lifecycle submissions is a good starting point.<\/p>\n<h2>Step four: watch the detail<\/h2>\n<p>Implementing and delegated acts will determine many operational details. National transposition of the Directive may also vary, so Greek requirements should be monitored separately.<\/p>\n<h2>A note on certainty<\/h2>\n<p>Dates in public commentary are estimates tied to Official Journal publication. Verify against the published text before committing resources.<\/p>\n<h2>How PQRA helps<\/h2>\n<p>PQRA offers a structured gap assessment against the reform, helps prioritise investment and builds a monitoring routine for guidance, implementing acts and Greek transposition.<\/p>\n<p><strong><a href=\"\/el\/contact\/\">Contact PQRA to discuss your situation<\/a><\/strong><\/p>","protected":false},"excerpt":{"rendered":"<p>With the reform of EU pharmaceutical legislation moving towards publication, companies have a window to prepare. A phased approach avoids both premature spending and last-minute scrambling. Step one: map your portfolio Classify products by status: authorised, under assessment, planned for submission before late 2028, or planned after. Published analyses indicate that procedures submitted before the [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1285,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"saved_in_kubio":false,"_swpsp_post_exclude":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1248","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Preparing for the EU Pharma Reform: A Practical Readiness Checklist for Marketing Authorisation Holders - PQRA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pqra.gr\/el\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\/\" \/>\n<meta property=\"og:locale\" content=\"el_GR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Preparing for the EU Pharma Reform: A Practical Readiness Checklist for Marketing Authorisation Holders - PQRA\" \/>\n<meta property=\"og:description\" content=\"With the reform of EU pharmaceutical legislation moving towards publication, companies have a window to prepare. A phased approach avoids both premature spending and last-minute scrambling. Step one: map your portfolio Classify products by status: authorised, under assessment, planned for submission before late 2028, or planned after. Published analyses indicate that procedures submitted before the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pqra.gr\/el\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\/\" \/>\n<meta property=\"og:site_name\" content=\"PQRA\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-02T06:59:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-02T07:03:09+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u03a3\u03c5\u03bd\u03c4\u03ac\u03c7\u03b8\u03b7\u03ba\u03b5 \u03b1\u03c0\u03cc\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u0395\u03ba\u03c4\u03b9\u03bc\u03ce\u03bc\u03b5\u03bd\u03bf\u03c2 \u03c7\u03c1\u03cc\u03bd\u03bf\u03c2 \u03b1\u03bd\u03ac\u03b3\u03bd\u03c9\u03c3\u03b7\u03c2\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u03bb\u03b5\u03c0\u03c4\u03cc\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#\\\/schema\\\/person\\\/31e1a03125e7281efaddd7278681af2c\"},\"headline\":\"Preparing for the EU Pharma Reform: A Practical Readiness Checklist for Marketing Authorisation Holders\",\"datePublished\":\"2026-11-02T06:59:11+00:00\",\"dateModified\":\"2026-11-02T07:03:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\\\/\"},\"wordCount\":259,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pqra.gr\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/pqra-cover-18.png\",\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"el\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.pqra.gr\\\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\\\/\",\"url\":\"https:\\\/\\\/www.pqra.gr\\\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\\\/\",\"name\":\"Preparing for the EU Pharma Reform: A Practical Readiness Checklist for Marketing Authorisation Holders - PQRA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pqra.gr\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/pqra-cover-18.png\",\"datePublished\":\"2026-11-02T06:59:11+00:00\",\"dateModified\":\"2026-11-02T07:03:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\\\/#breadcrumb\"},\"inLanguage\":\"el\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pqra.gr\\\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"el\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.pqra.gr\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/pqra-cover-18.png\",\"contentUrl\":\"https:\\\/\\\/www.pqra.gr\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/pqra-cover-18.png\",\"width\":1200,\"height\":630},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pqra.gr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Preparing for the EU Pharma Reform: A Practical Readiness Checklist for Marketing Authorisation Holders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#website\",\"url\":\"https:\\\/\\\/www.pqra.gr\\\/\",\"name\":\"PQRA\",\"description\":\"Your trusted partner in Pharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pqra.gr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"el\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#organization\",\"name\":\"PQRA\",\"url\":\"https:\\\/\\\/www.pqra.gr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"el\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.pqra.gr\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/pqra-logo-white.png\",\"contentUrl\":\"https:\\\/\\\/www.pqra.gr\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/pqra-logo-white.png\",\"width\":594,\"height\":362,\"caption\":\"PQRA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#\\\/schema\\\/person\\\/31e1a03125e7281efaddd7278681af2c\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"el\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/656b750ec6bc02db9de84dc3080e82be722c7777ef23ff04d6e8e7a0ac541a45?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/656b750ec6bc02db9de84dc3080e82be722c7777ef23ff04d6e8e7a0ac541a45?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/656b750ec6bc02db9de84dc3080e82be722c7777ef23ff04d6e8e7a0ac541a45?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\\\/\\\/www.pqra.gr\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Preparing for the EU Pharma Reform: A Practical Readiness Checklist for Marketing Authorisation Holders - PQRA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pqra.gr\/el\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\/","og_locale":"el_GR","og_type":"article","og_title":"Preparing for the EU Pharma Reform: A Practical Readiness Checklist for Marketing Authorisation Holders - PQRA","og_description":"With the reform of EU pharmaceutical legislation moving towards publication, companies have a window to prepare. A phased approach avoids both premature spending and last-minute scrambling. Step one: map your portfolio Classify products by status: authorised, under assessment, planned for submission before late 2028, or planned after. Published analyses indicate that procedures submitted before the [&hellip;]","og_url":"https:\/\/www.pqra.gr\/el\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\/","og_site_name":"PQRA","article_published_time":"2026-11-02T06:59:11+00:00","article_modified_time":"2026-11-02T07:03:09+00:00","author":"admin","twitter_card":"summary_large_image","twitter_misc":{"\u03a3\u03c5\u03bd\u03c4\u03ac\u03c7\u03b8\u03b7\u03ba\u03b5 \u03b1\u03c0\u03cc":"admin","\u0395\u03ba\u03c4\u03b9\u03bc\u03ce\u03bc\u03b5\u03bd\u03bf\u03c2 \u03c7\u03c1\u03cc\u03bd\u03bf\u03c2 \u03b1\u03bd\u03ac\u03b3\u03bd\u03c9\u03c3\u03b7\u03c2":"1 \u03bb\u03b5\u03c0\u03c4\u03cc"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pqra.gr\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\/#article","isPartOf":{"@id":"https:\/\/www.pqra.gr\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\/"},"author":{"name":"admin","@id":"https:\/\/www.pqra.gr\/#\/schema\/person\/31e1a03125e7281efaddd7278681af2c"},"headline":"Preparing for the EU Pharma Reform: A Practical Readiness Checklist for Marketing Authorisation Holders","datePublished":"2026-11-02T06:59:11+00:00","dateModified":"2026-11-02T07:03:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pqra.gr\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\/"},"wordCount":259,"commentCount":0,"publisher":{"@id":"https:\/\/www.pqra.gr\/#organization"},"image":{"@id":"https:\/\/www.pqra.gr\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pqra.gr\/wp-content\/uploads\/2026\/11\/pqra-cover-18.png","articleSection":["Uncategorized"],"inLanguage":"el","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.pqra.gr\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.pqra.gr\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\/","url":"https:\/\/www.pqra.gr\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\/","name":"Preparing for the EU Pharma Reform: A Practical Readiness Checklist for Marketing Authorisation Holders - PQRA","isPartOf":{"@id":"https:\/\/www.pqra.gr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pqra.gr\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\/#primaryimage"},"image":{"@id":"https:\/\/www.pqra.gr\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pqra.gr\/wp-content\/uploads\/2026\/11\/pqra-cover-18.png","datePublished":"2026-11-02T06:59:11+00:00","dateModified":"2026-11-02T07:03:09+00:00","breadcrumb":{"@id":"https:\/\/www.pqra.gr\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\/#breadcrumb"},"inLanguage":"el","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pqra.gr\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\/"]}]},{"@type":"ImageObject","inLanguage":"el","@id":"https:\/\/www.pqra.gr\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\/#primaryimage","url":"https:\/\/www.pqra.gr\/wp-content\/uploads\/2026\/11\/pqra-cover-18.png","contentUrl":"https:\/\/www.pqra.gr\/wp-content\/uploads\/2026\/11\/pqra-cover-18.png","width":1200,"height":630},{"@type":"BreadcrumbList","@id":"https:\/\/www.pqra.gr\/preparing-for-the-eu-pharma-reform-a-practical-readiness-checklist-for-marketing-authorisation-holders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pqra.gr\/"},{"@type":"ListItem","position":2,"name":"Preparing for the EU Pharma Reform: A Practical Readiness Checklist for Marketing Authorisation Holders"}]},{"@type":"WebSite","@id":"https:\/\/www.pqra.gr\/#website","url":"https:\/\/www.pqra.gr\/","name":"PQRA","description":"Your trusted partner in Pharma","publisher":{"@id":"https:\/\/www.pqra.gr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pqra.gr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"el"},{"@type":"Organization","@id":"https:\/\/www.pqra.gr\/#organization","name":"PQRA","url":"https:\/\/www.pqra.gr\/","logo":{"@type":"ImageObject","inLanguage":"el","@id":"https:\/\/www.pqra.gr\/#\/schema\/logo\/image\/","url":"https:\/\/www.pqra.gr\/wp-content\/uploads\/2026\/07\/pqra-logo-white.png","contentUrl":"https:\/\/www.pqra.gr\/wp-content\/uploads\/2026\/07\/pqra-logo-white.png","width":594,"height":362,"caption":"PQRA"},"image":{"@id":"https:\/\/www.pqra.gr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.pqra.gr\/#\/schema\/person\/31e1a03125e7281efaddd7278681af2c","name":"admin","image":{"@type":"ImageObject","inLanguage":"el","@id":"https:\/\/secure.gravatar.com\/avatar\/656b750ec6bc02db9de84dc3080e82be722c7777ef23ff04d6e8e7a0ac541a45?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/656b750ec6bc02db9de84dc3080e82be722c7777ef23ff04d6e8e7a0ac541a45?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/656b750ec6bc02db9de84dc3080e82be722c7777ef23ff04d6e8e7a0ac541a45?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/www.pqra.gr"]}]}},"_links":{"self":[{"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/posts\/1248","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/comments?post=1248"}],"version-history":[{"count":1,"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/posts\/1248\/revisions"}],"predecessor-version":[{"id":1286,"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/posts\/1248\/revisions\/1286"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/media\/1285"}],"wp:attachment":[{"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/media?parent=1248"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/categories?post=1248"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/tags?post=1248"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}